Implementable strategies and exploratory considerations to reduce costs associated with anti-TNF therapy in inflammatory bowel disease
about
Progress in the treatment and outcome of pediatric inflammatory bowel disease patients.Health outcomes and cost-effectiveness of certolizumab pegol in the treatment of Crohn's disease.Optimizing Treatment with TNF Inhibitors in Inflammatory Bowel Disease by Monitoring Drug Levels and Antidrug Antibodies.Predictors of Early Readmission in Hospitalized Patients with Inflammatory Bowel Disease.Assuring Quality for Non-Hospital Based Biologic Infusions in Pediatric Inflammatory Bowel Disease: A Clinical Report from the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition.
P2860
Implementable strategies and exploratory considerations to reduce costs associated with anti-TNF therapy in inflammatory bowel disease
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Implementable strategies and e ...... in inflammatory bowel disease
@en
Implementable strategies and e ...... in inflammatory bowel disease.
@nl
type
label
Implementable strategies and e ...... in inflammatory bowel disease
@en
Implementable strategies and e ...... in inflammatory bowel disease.
@nl
prefLabel
Implementable strategies and e ...... in inflammatory bowel disease
@en
Implementable strategies and e ...... in inflammatory bowel disease.
@nl
P2093
P2860
P921
P1476
Implementable strategies and e ...... in inflammatory bowel disease
@en
P2093
Dana M H Dykes
Ian H Leibowitz
Jacqueline Fridge
Michael D Kappelman
Richard B Colletti
Wallace V Crandall
P2860
P304
P356
10.1097/01.MIB.0000441349.40193.AA
P577
2014-05-01T00:00:00Z